As of January 2025, GeneFerm Biotechnology has a market cap of $57.82M. This makes GeneFerm Biotechnology the world's 22586th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $74.17M | -21.48% |
2023 | $94.46M | 11.36% |
2022 | $84.82M | 50.85% |
2021 | $56.23M | 52.41% |
2020 | $36.90M | -4.90% |
2019 | $38.80M | -27.14% |
2018 | $53.25M | -23.36% |
2017 | $69.48M | -33.98% |
2016 | $105.24M | - |